What is Savara's interest income (expense), nonoperating?

Savara (SVRA) reported interest income (expense), nonoperating of $1.06M in Q1 2026.

How has Savara's interest income (expense), nonoperating changed year-over-year?

Savara's interest income (expense), nonoperating decreased by 29.4% year-over-year, from $1.5M to $1.06M.

What is the long-term trend for Savara's interest income (expense), nonoperating?

Over 3 years (2021 to 2025), Savara's interest income (expense), nonoperating has grown at a 22.2% compound annual growth rate (CAGR), from -$2.28M to $4.16M.

Savara SVRA Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

ANI PharmaceuticalsANIP

——

Eton Pharmaceuticals, Inc.ETON

——

Amneal Pharmaceuticals, Inc.AMRX

——

AdaptHealthAHCO

——

Acadia PharmaceuticalsACAD

——

Other financials

Income statement

See full

Revenue-—

Operating income-$39.0M-37.1%

Net income-$37.3M-40.0%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$38.8M+98.4%

Total debt$30.1M+1.8%

Total equity$176.0M+19.1%

Total assets$221.6M+17.1%

Cash flow

See full

Operating cash flow-$33.0M-21.5%

CapEx$54.0K+1,700%

Free cash flow-$33.1M-21.7%

Valuation

See full

Market cap$1.19B+236%

Enterprise value$1.19B+224%

P/S4,648.7×—

Profitability

See full

Operating margin-19,183.3%—

Net margin-19,305.1%—

FCF margin-15,518.7%—

Returns & leverage

See full

Return on equity-80%+4.7pp

Debt / equity0.2×0.0×

Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Savara's interest income (expense), nonoperating?: Savara (SVRA) reported interest income (expense), nonoperating of $1.06M in Q1 2026.
How has Savara's interest income (expense), nonoperating changed year-over-year?: Savara's interest income (expense), nonoperating decreased by 29.4% year-over-year, from $1.5M to $1.06M.
What is the long-term trend for Savara's interest income (expense), nonoperating?: Over 3 years (2021 to 2025), Savara's interest income (expense), nonoperating has grown at a 22.2% compound annual growth rate (CAGR), from -$2.28M to $4.16M.